… IC 50 values for artesunate and erlotinib and subsequently subjected to hierarchical cluster
… In conclusion, the combination treatment of artesunate and erlotinib resulted in synergistic …

… with erlotinib are driving the development of the phase III program, and ongoing phase Ib
and II trials are also in progress to evaluate erlotinib as monotherapy or combination therapy in …

… a rational experimental combination regimen. Compared … combination therapy using an
EGFR-tyrosine kinase inhibitor and a COX-2 inhibitor. The rationale for this combination therapy …

… resistance to gefitinib and erlotinib. Our findings suggest that the combination of a Met-TKI
and a mutant-selective EGFR-TKI may be effective in controlling these resistant tumors. …

… -based regimens with erlotinib. In the Phase I study of erlotinib in combination with carboplatin
and … Erlotinib combination therapy has been evaluated in metastatic breast cancer with …

… The combination of bevacizumab plus erlotinib showed promising interim results for HLRCC-…
Based on these results, we analyzed the outcome of bevacizumab plus erlotinib in Korean …

… and oral erlotinib combination therapy for choroidal … : Combining intravitreal bevacizumab
and oral erlotinib could … , combining intravitreal bevacizumab and oral erlotinib could …

… requiring a dose reduction during the first 28 days of combination therapy, and (d) any
toxicity resulting in a treatment delay of >1 week during the first 28 days of combination therapy. …

… High-grade neutropenia and electrolyte disturbances previously reported with TLR9 agonists
combined with platinum-based therapy were not observed in this study. Five of 33 patients …

… The antitumor activity of erlotinib as single-agent therapy has … Erlotinib is also being evaluated
in combination with … have already failed first line therapy with gemcitabine. The regimen …